-transparent.png){kind=logo}
The effect of cis-diamminedichloro platinum (II) (CDDP) was evaluated in 14 patients with advanced pancreatic carcinoma. Prior chemotherapy was done in 7 cases and the remaining 7 were fresh cases. The drug was given at a dose of 80 mg/m2 I.V. every 3 weeks, with hydration and mannitol diuresis. Four cases out of 14 showed no change, while the remaining 10 cases showed progressive disease. The response rate was 0%. Most of the patients who showed myelosuppression had received prior chemotherapy. Non-hematologic toxicity occurred in 9 patients (64%) and consisted of nausea in 9, vomiting in 7 and anorexia in 9. Values of serum creatinine and BUN were transiently elevated.
Related Publications
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
September 1984,
Hinyokika kiyo. Acta urologica Japonica,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
December 1983,
Journal of surgical oncology,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
December 1978,
The Journal of urology,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
April 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
July 1984,
Gynecologic oncology,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
January 1980,
Cancer treatment reports,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
December 1984,
Hinyokika kiyo. Acta urologica Japonica,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
August 1987,
Journal of surgical oncology,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
January 1980,
Cancer treatment reports,
H Tajiri, and
M Yoshimori, and
A Hijikata, and
K Nakamura, and
H Ohkura, and
N Okazaki
February 1981,
Cancer,
